Rs 250 Crore Expansion! This FMCG Player Opens New Indonesia Plant

Rs 250 Crore Expansion! This FMCG Player Opens New Indonesia Plant

Godrej Consumer Products Indonesia has inaugurated the first phase of its Kendal manufacturing facility, part of an IDR 500 billion investment aimed at expanding home and personal care capacity by about 15 per cent.

✨ Key Takeaways

Godrej Consumer Products Indonesia, the Indonesian subsidiary of Godrej Consumer Products Ltd, has inaugurated the first phase of a new manufacturing facility at the Kendal Special Economic Zone, backing its plan to increase home and personal care capacity by about 15 per cent.

The project is part of an IDR 500 billion investment, equivalent to around Rs 250 crore, and comes as the company’s existing Indonesian manufacturing network operates at 75-80 per cent utilisation. The additional capacity is intended to meet demand growth in Indonesia and create a larger base for regional exports.

The first phase, inaugurated on October 6, 2026, occupies 2.5 hectares of GCPI’s 5.5-hectare site in Kendal and will manufacture household insecticide products. This is a strategically relevant category for the company, whose Indonesian portfolio includes HIT, Stella, Mitu and NYU. The brands reach about one in four Indonesian households, according to the company.

The capacity addition follows an improvement in the Indonesian business during the June quarter. GCPL had reported 15 per cent sales growth in Indonesia during the first quarter of FY2027, with underlying volume growth of 10 per cent, led by shampoo, hair colour and household insecticides. The Kendal investment therefore moves beyond a replacement or maintenance project, providing room for the business to scale if the recent recovery in demand and category execution is sustained.

Looking for High-Growth Micro Cap Opportunities?

Explore DSIJ’s Micro Marvel - a research-driven service focused on fundamentally strong microcap stocks with the potential to create long-term wealth through high-growth opportunities.

Download Service Brochure

Aasif Malbari, Managing Director and Chief Executive Officer of GCPL, said the company sees significant growth headroom in Indonesia and expects the Kendal facility to support rising regional demand. ‘Our IDR 500 billion investment in the new Indonesian plant will expand home and personal care categories capacity by approximately 15 per cent,’ he said, adding that the site could become an export platform for the region.

GCPI has operated in Indonesia since 2010 and its business has grown 4.5 times over that period. Indonesia is one of GCPL’s important overseas markets and forms part of its wider strategy to strengthen manufacturing, local product development and distribution in emerging markets.

The facility was built in just over a year, with technology and data systems integrated into operations from inception. Rajesh Sethuraman, Business Head, Indonesia and Global Head of Business Transformation and Digital at GCPL, said the model would provide better visibility into demand and enable quicker operating decisions and product innovation.

The new plant also complements the company’s existing Jakarta research and development laboratory, which focuses on air care, home insecticides, home care and personal care. The combination of local research capability and fresh manufacturing capacity could help GCPI shorten the route from consumer insights to product launches, particularly in categories where demand and seasonality can move quickly.

For investors, the project underlines GCPL’s willingness to continue investing in Indonesia despite near-term pressure from crude-linked commodity costs. In the June quarter, the company’s consolidated net sales rose 15.4 per cent year-on-year to Rs 4,225.47 crore, while operating margin excluding other income remained broadly flat year-on-year at 18.96 per cent. Management had flagged unusually sharp inflation in LPG, kerosene and other inputs as a temporary drag on Indian margins.

As of 3:55 pm on October 6, 2026, GCPL shares were trading at Rs 872, up 3.44 per cent from the previous close of Rs 843. The stock was still about 30.4 per cent below its 52-week high of Rs 1,253.65 and only 3.4 per cent above its 52-week low of Rs 843. Over the past year, the shares have declined 31.59 per cent, compared with a 3.22 per cent fall in the BSE 500.

The key execution question will be the pace at which GCPI can utilise the added capacity, especially as the first phase is focused on household insecticides, a category influenced by weather patterns and seasonal demand. The full 5.5-hectare Kendal site nevertheless gives GCPL further scope for expansion if demand continues to build across Indonesia and neighbouring export markets.

Disclaimer: The article is for informational purposes only and not investment advice.